Search Results 451-460 of 18044 for progesterone

  1. Propylthiouracil (oral route) - Side effects & dosage - Mayo Clinic

    Propylthiouracil is used to treat Graves' disease and hyperthyroidism, a condition where the thyroid gland produces too much thyroid hormone. It is also used ...

  2. Medical Research & Education - Mayo Clinic News Network

    JACKSONVILLE, Fla. — A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking ...

  3. Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy - Mayo Clinic

    Histologically confirmed adenocarcinoma of the breast stage 0-III with estrogen receptor (ER) and/or progesterone receptor (PR) positive per ASCO/CAP ...

  4. Primary ovarian insufficiency - Symptoms and causes - Mayo Clinic

    This condition, also called premature ovarian failure, happens in women under age 40. Hormone therapy can lessen symptoms.

  5. Assess Glycemic Improvements in People with Type 2 Diabetes Using a Novel Hybrid Closed Loop Insulin Pump - Mayo Clinic

    Combined estrogen and progesterone containing hormonal contraception associated with inhibition ofovulation (oral, intravaginal, transdermal). Progestogen ...

  6. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) (MV-s-NAP) in Patients with Metastatic Breast Cancer - Mayo Clinic

    * Pathologically confirmed invasive breast adenocarcinoma with documented estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor ...

  7. A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy - Mayo Clinic

    Use of oral (estrogen and progesterone), injected or implanted combined hormonal methods of contraception or placement of an intrauterine device (IUD) or ...

  8. Medical Research & Education - Mayo Clinic News Network

    JACKSONVILLE, Fla. — A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking ...

  9. Medical Research & Education - Mayo Clinic News Network

    JACKSONVILLE, Fla. — A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking ...

  10. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

    ... progesterone receptor (PR) status; hormone receptor negative status must be determined by both known negative ER and known negative PR - Patients with ...